Kinetics of the multidrug transporter (P-glycoprotein) and its reversal

被引:228
作者
Stein, WD
机构
[1] Department of Biological Chemistry, Silberman Institute of Life Sciences, Hebrew University, Jerusalem
关键词
D O I
10.1152/physrev.1997.77.2.545
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Most cancer deaths result from the cancer's either being intrinsically resistant to chemotherapeutic drugs or becoming resistant after being initially sensitive. Often, in cells grown in cell culture, drug resistance correlates with the presence of one or more of the so-called P-glycoproteins or multidrug resistance proteins, products of the mdr family of genes. This review is largely concerned with the transport kinetics of the P-glycoproteins. We first present a brief overview of the P-glycoproteins, their properties, and their clinical significance. Later sections of the review expand on this material with special emphasis on the substrates of P-glycoprotein and how they cross the cell membrane, on the transport kinetics of the P-glycoprotein, on reversers of its action, and on its activity as an ATPase. In a final section, we consider the mechanism of action of P-glycoprotein as an actively transporting membrane pump. The characteristic of P-glycoprotein considered the most difficult to explain is its very broad specificity (or lack of specificity), but there are precedents for this property in well-known proteins such as serum albumin, which binds a range of molecular types, including substrates and reversers of P-glycoprotein, seemingly as broad as does P-glycoprotein. Pointing out this analogy does not provide a molecular explanation for the substrate-binding properties of P-glycoprotein but does make those properties more assimilable.
引用
收藏
页码:545 / 590
页数:46
相关论文
共 264 条
  • [1] THE MULTIDRUG RESISTANCE (MDR1) GENE-PRODUCT FUNCTIONS AS AN ATP CHANNEL
    ABRAHAM, EH
    PRAT, AG
    GERWECK, L
    SENEVERATNE, T
    ARCECI, RJ
    KRAMER, R
    GUIDOTTI, G
    CANTIELLO, HF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) : 312 - 316
  • [2] REGULATION OF ION CHANNELS BY ABC TRANSPORTERS THAT SECRETE ATP
    ALAWQATI, Q
    [J]. SCIENCE, 1995, 269 (5225) : 805 - 806
  • [3] ALLEN LM, 1978, CANCER RES, V38, P2549
  • [4] ALMQUIST KC, 1995, CANCER RES, V55, P102
  • [5] ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
  • [6] ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986
  • [7] UNIDIRECTIONAL FLUXES OF RHODAMINE-123 IN MULTIDRUG-RESISTANT CELLS - EVIDENCE AGAINST DIRECT DRUG EXTRUSION FROM THE PLASMA-MEMBRANE
    ALTENBERG, GA
    VANOYE, CG
    HORTON, JK
    REUSS, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4654 - 4657
  • [8] GENERATION OF A DRUG-RESISTANCE PROFILE BY QUANTITATION OF MDR-1/P-GLYCOPROTEIN IN THE CELL-LINES OF THE NATIONAL-CANCER-INSTITUTE ANTICANCER DRUG SCREEN
    ALVAREZ, M
    PAULL, K
    MONKS, A
    HOSE, C
    LEE, JS
    WEINSTEIN, J
    GREVER, M
    BATES, S
    FOJO, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) : 2205 - 2214
  • [9] PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS
    AMBUDKAR, SV
    LELONG, IH
    ZHANG, JP
    CARDARELLI, CO
    GOTTESMAN, MM
    PASTAN, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) : 8472 - 8476
  • [10] ADDING A REVERSER (VERAPAMIL) TO COMBINED CHEMOTHERAPY OVERRIDES RESISTANCE IN SMALL-CELL LUNG-CANCER XENOGRAFTS
    ARVELO, F
    POUPON, MF
    BICHAT, F
    GROSSIN, F
    BOURGEOIS, Y
    JACROT, M
    BASTIAN, G
    LECHEVALIER, T
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) : 1862 - 1868